Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO WCGIC 2020 | Impact of COVID-19 on esophageal cancer treatment

Omkara Veeranki • 1 Jul 2020
ESMO WCGIC 2020
Esophageal Cancer Gastrointestinal Cancer

Omkara Veeranki, MD, of the University of Texas MD Anderson Cancer Center, Houston, TX, discusses the impact of COVID-19 on the treatment of esophageal cancer as well as clinical research. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Omkara Veeranki

1:28
Future approaches in esophageal cancer
Omkara Veeranki • 1 Jul 2020
6:21
Patient-derived orthotopic xenograft models of esophageal adenocarcinoma
Omkara Veeranki • 1 Jul 2020

Related Videos

1:53
Important pathophysiological determinants of elevated cirDNA post-surgery
Alain Thierry • 9 Apr 2024
0:47
Emerging molecular drivers and biomarker targets in gastroesophageal cancers
Tatsuhiro Shibata • 9 Apr 2024
0:52
DRP-104 with durvalumab in fibrolamellar hepatocellular carcinoma
Marina Baretti • 9 Apr 2024
1:06
The emerging role of cancer vaccines in treating liver cancer
Marina Baretti • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals